ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Intensive Care Cardiovascular Medicine

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1600012

This article is part of the Research TopicInnovative Monitoring and Management of Perioperative Complications in Cardiac SurgeryView all 7 articles

Deep Learning-Based Prediction Model of Acute Kidney Injury Following Coronary Artery Bypass Grafting in Coronary Heart Disease Patients: A Multicenter Clinical Study from China

Provisionally accepted
Biao  HouBiao Hou1Tingting  LiuTingting Liu1Pengyun  YanPengyun Yan2Yuqing  WangYuqing Wang3Xuejian  HouXuejian Hou1Liang  LiLiang Li4Haiping  YangHaiping Yang5Lin  ChenLin Chen5Taoshuai  LiuTaoshuai Liu1Zhang  KuiZhang Kui1Shijun  XuShijun Xu1Yang  LiYang Li1*Ran  DongRan Dong1*
  • 1Beijing Anzhen Hospital, Capital Medical University, Chaoyang District, China
  • 2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China
  • 3Jinan No. 3 People's Hospital, Jinan, Shandong Province, China
  • 4Handan First Hospital, Handan, Hebei Province, China
  • 5Beijing Luhe Hospital, Capital Medical University, Beijing, Beijing Municipality, China

The final, formatted version of the article will be published soon.

Off-pump coronary artery bypass grafting (OPCABG) is an alternative to traditional CABG, avoiding cardiopulmonary bypass. However, acute kidney injury (AKI) remains a common complication, with incidence rates ranging from 5% to 42%, significantly affecting postoperative outcomes.This study aimed to develop a robust risk prediction model for post-OPCABG AKI using machine learning (ML) techniques. We conducted a multicenter retrospective study with 3,043 coronary artery disease (CAD) patients, with an overall AKI incidence of 15.28%. The cohort was divided into a training set (n=2,130) and a validation set (n=913), and an external validation cohort of 878 patients was included. Five ML methods -SVM, Decision Tree (DT), Random Forest (RF), AdaBoost, and XGBoostwere employed to predict AKI risk. The XGBoost model showed the highest performance, with an area under the curve (AUC) of 0.88, sensitivity of 82%, and specificity of 83% in the internal validation set. In the external validation set, it achieved an AUC of 0.84, sensitivity of 74%, and specificity of 90%. The model utilized 26 predictive features, including patient demographics and preoperative laboratory values. The XGBoost model outperformed other methods (SVM, DT, RF, and AdaBoost) in both internal and external validation, demonstrating its robustness and generalizability. By integrating diverse patient data from multiple institutions, our model improved AKI risk assessment and identified novel predictive factors using advanced ML algorithms. These findings highlight the potential of machine learning models in enhancing AKI risk prediction and supporting personalized management strategies to improve outcomes in OPCABG patients.

Keywords: OPCABG, AKI, machine learning, XGBoost, CAD

Received: 25 Mar 2025; Accepted: 09 Jun 2025.

Copyright: © 2025 Hou, Liu, Yan, Wang, Hou, Li, Yang, Chen, Liu, Kui, Xu, Li and Dong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Yang Li, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District, China
Ran Dong, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.